keyword
https://read.qxmd.com/read/38610983/distinct-prostate-cancer-survival-outcomes-in-firefighters-a-population-based-study
#21
JOURNAL ARTICLE
Paulo S Pinheiro, Tulay Koru-Sengul, Wei Zhao, Diana R Hernandez, Monique N Hernandez, Erin N Kobetz, Alberto J Caban-Martinez, David J Lee
Introduction: Survival outcomes for prostate cancer among specific occupational groups prone to regular medical check-ups vis-à-vis the general population have been understudied. For firefighters, a demographic subject to rigorous medical evaluations, possessing above-average medical expertise, and exposed to specific carcinogens of interest, prostate cancer survival in the US has never been studied. Methods: We conducted a retrospective study, utilizing data from the Florida Cancer Data System spanning 2004 to 2014, coupled with firefighter certification records from the Florida State Fire Marshal's Office...
March 27, 2024: Cancers
https://read.qxmd.com/read/38608782/long-term-evaluation-of-optimized-gleason-grading-in-a-large-cohort-of-men-with-prostate-cancer-in-canada
#22
JOURNAL ARTICLE
Michel Wissing, Fadi Brimo, Ginette McKercher, Eleonora Scarlata, Fred Saad, Michel Carmel, Louis Lacombe, Bernard Têtu, Nadia Ekindi-Ndongo, Mathieu Latour, Dominique Trudel, Simone Chevalier, Armen Aprikian
OBJECTIVES: To evaluate the International Society of Urological Pathology (ISUP) 5-tier grade grouping (GG) system of prostate cancers as well as previously proposed optimizations. PATIENTS AND METHODS: The PROCURE biobank is a prospective cohort study of patients with localized prostate cancer who underwent radical prostatectomy in Quebec province between 2005 and 2013. Surgical specimens were graded by experienced genitourinary pathologists using 2019 ISUP criteria...
April 10, 2024: Human Pathology
https://read.qxmd.com/read/38606110/predictive-model-of-positive-surgical-margins-after-radical-prostatectomy-based-on-bayesian-network-analysis
#23
JOURNAL ARTICLE
Guipeng Wang, Haotian Du, Fanshuo Meng, Yuefeng Jia, Xinning Wang, Xuecheng Yang
OBJECTIVE: This study aimed to analyze the independent risk factors for marginal positivity after radical prostatectomy and to evaluate the clinical value of the predictive model based on Bayesian network analysis. METHODS: We retrospectively analyzed the clinical data from 238 patients who had undergone radical prostatectomy, between June 2018 and May 2022. The general clinical data, prostate specific antigen (PSA)-derived indicators, puncture factors, and magnetic resonance imaging (MRI) characteristics were included as predictive variables, and univariate and multivariate analyses were conducted...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38604492/impact-of-tricuspid-regurgitation-on-outcomes-after-transcatheter-mitral-valve-replacement
#24
JOURNAL ARTICLE
Hiroki A Ueyama, Giancarlo Licitra, Patrick T Gleason, Omid Behbahani-Nejad, Roshan Modi, Dhiren Rajagopal, Isida Byku, Joe X Xie, Adam B Greenbaum, Gaetano Paone, W Brent Keeling, Kendra J Grubb, George S Hanzel, Chandan M Devireddy, Peter C Block, Vasilis C Babaliaros
Development of functional tricuspid regurgitation (TR) because of chronic mitral disease and subsequent heart failure is common. However, the effect of TR on clinical outcomes after transcatheter mitral valve replacement (TMVR) remains unclear. We aimed to evaluate the impact of baseline TR on outcomes after TMVR. This was a single-center, retrospective analysis of patients who received valve-in-valve or valve-in-ring TMVR between 2012 and 2022. Patients were categorized into none/mild TR and moderate/severe TR based on baseline echocardiography...
April 9, 2024: American Journal of Cardiology
https://read.qxmd.com/read/38602757/-a-single-center-study%C3%AF-an-analysis-of-the-safety-and-validity-of-delaying-repeated-biopsy-for-patients-with-atypical-small-acinar-proliferation
#25
JOURNAL ARTICLE
Wen-Tong Ji, De-Chuan Liu, Wan-Li Cui, Yu Hu, Yao Wang, Jiu-Feng Tan
OBJECTIVE: To explore the association between atypical small acinar proliferation (ASAP) and subsequent diagnosis of intermediate and high risk prostate cancer (PCa), and analyze whether delaying repeat biopsy timing is safe and effective. METHODS: From June 2000 to June 2022, we retrospectively analyzed the clinical data of 276 patients accepting prostatic biopsy and diagnosed with ASAP in China-Japan Union Hospital of Jilin University. 54.7% (151/276) patients had a repeat biopsy...
May 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38602755/-mechanism-study-on-the-effect-of-androgen-antagonism-in-prostate-cancer
#26
JOURNAL ARTICLE
Xu Song, Qiang Song, Rong Wang, Qing-Jun Zuo, Zhi-Yuan Zhang
OBJECTIVE: To explore the mechanism of tetrahydroxynonene (4-HNE) in the androgen antagonistic effect of prostate cancer through the androgen receptor (AR) - mitogen activated protein kinase (MAPK) signaling pathway. METHOD: Prostate cancer LNCaP cells were divided into wild-type group (NC, control group) and transfection group. The transfection group was further divided into empty vector transfection group (NC-L7 group) and GSTA4 gene transfection group (A0718, GSTA4-OE group)...
May 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38602754/-difference-between-prostate-cancer-patients-gleason-scores-from-preoperative-biopsy-and-those-from-postoperative-pathology
#27
JOURNAL ARTICLE
Xiao-Dong Zhao, You-Huang Liu, Jun Hu, Zu-Heng Wang, Xiao-Xu Jin, Meng-Fei Ma, Yu-Lin Zhou, Yu-Hao Chen, Jie Cao, Jie Dong, Song Xu
OBJECTIVE: To evaluate the consistency of the Gleason scores of PCa patients based on preoperative biopsy with those from postoperative pathology, identify the possible factors influencing results of scoring, and construct a risk scoring model. METHODS: We collected the demographic and clinical data on the patients with PCa confirmed by preoperative prostate biopsy or postoperative pathology and treated by radical prostatectomy within 6 months after diagnosis. Using paired sample t-test, we identified the difference between the Gleason scores based on preoperative biopsy and those from postoperative pathology, analyzed the demographic and clinical data on the patients for relevant factors affecting the consistency of the Gleason scores, and calculated and visualized the relative risk values of the factors through Poisson regression...
May 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38600735/overcoming-lot-to-lot-variability-in-protein-activity-using-epitope-specific-calibration-free-concentration-analysis
#28
JOURNAL ARTICLE
Ian B Harvey, Shannon D Chilewski, Devyani Bhosale, Sarah E Tobia, Christopher Gray, Carol Gleason, Jonathan Haulenbeek
Concentration determination is a fundamental hallmark of protein reagent characterization, providing a means to ensure reproducibility and unify measurements from various assays. However, lot-to-lot differences in protein activity often still occur, leading to uncertainty in the accuracy of downstream measurements. Here, we postulate that those differences are caused by a misrepresentation of the protein concentration as measured by traditional total protein techniques, which can include multiple types of inactive protein species...
April 10, 2024: Analytical Chemistry
https://read.qxmd.com/read/38596625/challenges-in-utilizing-alk-expression-to-distinguish-primary-cutaneous-from-systemic-anaplastic-large-cell-lymphoma
#29
JOURNAL ARTICLE
Laura Gleason, Ladan Afifi, Lauren Banner, Sahithi Talasila, Daniel Joffe, Safiyyah Bhatti, Onder Alpdogan, Pierluigi Porcu, Neda Nikbakht
Anaplastic large cell lymphoma (ALCL) is a CD30+ peripheral T-cell lymphoma with a clinical spectrum including cutaneous and systemic presentations. While primary cutaneous ALCL (pcALCL) has a favorable prognosis, systemic ALCL (sALCL) has poorer survival outcomes. Expression of anaplastic lymphoma kinase (ALK) by malignant cells has been suggested to distinguish sALCL from pcALCL. However, there have been documented cases of ALK-positive ALCL confined to the skin. The present study reviewed characteristics of published cutaneous ALK-positive ALCL cases to distinguish between these two entities...
May 2024: Molecular and Clinical Oncology
https://read.qxmd.com/read/38596483/the-australian-multidomain-approach-to-reduce-dementia-risk-by-protecting-brain-health-with-lifestyle-intervention-study-au-arrow-a-study-protocol-for-a-single-blind-multi-site-randomized-controlled-trial
#30
JOURNAL ARTICLE
Samantha L Gardener, Stephanie J Fuller, Sharon L Naismith, Laura Baker, Miia Kivipelto, Victor L Villemagne, Stuart M Grieve, Paul Yates, Stephanie R Rainey-Smith, Juliana Chen, Belinda Thompson, Nicola J Armstrong, Malika G Fernando, Carolina Blagojevic Castro, Silochna Meghwar, Rema Raman, Andrew Gleason, Catriona Ireland, Roger Clarnette, Kaarin J Anstey, Kevin Taddei, Manohar Garg, Hamid R Sohrabi, Ralph N Martins
INTRODUCTION: The Finnish Geriatric Intervention Study (FINGER) led to the global dementia risk reduction initiative: World-Wide FINGERS (WW-FINGERS). As part of WW-FINGERS, the Australian AU-ARROW study mirrors aspects of FINGER, as well as US-POINTER. METHOD: AU-ARROW is a randomized, single-blind, multisite, 2-year clinical trial ( n = 600; aged 55-79). The multimodal lifestyle intervention group will engage in aerobic exercise, resistance training and stretching, dietary advice to encourage MIND diet adherence, BrainHQ cognitive training, and medical monitoring and health education...
2024: Alzheimer's & Dementia: Translational Research & Clinical Interventions
https://read.qxmd.com/read/38595837/concomitant-bilateral-inferior-gluteal-lymph-node-involvement-in-metastatic-prostate-adenocarcinoma-detected-on-68-gallium-prostate-specific-membrane-antigen-positron-emission-tomography-computed-tomography
#31
Parth Baberwal, Sunita Sonavane, Sandip Basu
An unusual and unique case of prostate adenocarcinoma with involvement of bilateral inferior gluteal lymph nodes is reported. The patient was a 42-year-old male, with conventional prostatic adenocarcinoma (Gleason score: 5 + 4 = 9), who, during disease progression with rising serum prostate specific antigen levels following medical androgen deprivation therapy, demonstrated new prostate-specific membrane antigen expressing metastatic intermuscular deposits in the bilateral gluteal region, subsequently proven to be bilateral inferior gluteal nodal metastasis...
March 2024: World Journal of Nuclear Medicine
https://read.qxmd.com/read/38594676/targeting-transitioning-lung-monocytes-macrophages-as-treatment-strategies-in-lung-disease-related-to-environmental-exposures
#32
JOURNAL ARTICLE
Aaron D Schwab, Todd A Wyatt, Grace Moravec, Geoffrey M Thiele, Amy J Nelson, Angela Gleason, Oliver Schanze, Michael J Duryee, Debra J Romberger, Ted R Mikuls, Jill A Poole
BACKGROUND: Environmental/occupational exposures cause significant lung diseases. Agricultural organic dust extracts (ODE) and bacterial component lipopolysaccharide (LPS) induce recruited, transitioning murine lung monocytes/macrophages, yet their cellular role remains unclear. METHODS: CCR2 RFP+ mice were intratracheally instilled with high concentration ODE (25%), LPS (10 μg), or gram-positive peptidoglycan (PGN, 100 μg) for monocyte/macrophage cell-trafficking studies...
April 9, 2024: Respiratory Research
https://read.qxmd.com/read/38594360/development-and-validation-of-a-deep-learning-based-microsatellite-instability-predictor-from-prostate-cancer-whole-slide-images
#33
JOURNAL ARTICLE
Qiyuan Hu, Abbas A Rizvi, Geoffery Schau, Kshitij Ingale, Yoni Muller, Rachel Baits, Sebastian Pretzer, Aïcha BenTaieb, Abigail Gordhamer, Roberto Nussenzveig, Adam Cole, Matthew O Leavitt, Ryan D Jones, Rohan P Joshi, Nike Beaubier, Martin C Stumpe, Kunal Nagpal
Microsatellite instability-high (MSI-H) is a tumor-agnostic biomarker for immune checkpoint inhibitor therapy. However, MSI status is not routinely tested in prostate cancer, in part due to low prevalence and assay cost. As such, prediction of MSI status from hematoxylin and eosin (H&E) stained whole-slide images (WSIs) could identify prostate cancer patients most likely to benefit from confirmatory testing to evaluate their eligibility for immunotherapy and need for Lynch syndrome testing. Prostate biopsies and surgical resections from prostate cancer patients referred to our institution were analyzed...
April 9, 2024: NPJ Precision Oncology
https://read.qxmd.com/read/38593599/an-update-on-the-role-of-mpmri-and-68-ga-psma-pet-imaging-in-primary-and-recurrent-prostate-cancer
#34
REVIEW
Hamed Bagheri, Seyed Rabi Mahdavi, Parham Geramifar, Ali Neshasteh-Riz, Masoumeh Sajadi Rad, Habibollah Dadgar, Hossein Arabi, Habib Zaidi
The objective of this work was to review comparisons of the efficacy of 68 Ga-PSMA-11 (prostate-specific membrane antigen) PET/CT and multiparametric magnetic resonance imaging (mpMRI) in the detection of prostate cancer among patients undergoing initial staging prior to radical prostatectomy or experiencing recurrent prostate cancer, based on histopathological data. A comprehensive search was conducted in PubMed and Web of Science, and relevant articles were analyzed with various parameters, including year of publication, study design, patient count, age, PSA (prostate-specific antigen) value, Gleason score, standardized uptake value (SUVmax ), detection rate, treatment history, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and PI-RADS (prostate imaging reporting and data system) scores...
March 13, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38592797/lgbq-affirming-clinical-recommendations-for%C3%A2-compulsive-sexual-behavior-disorder
#35
REVIEW
Todd L Jennings, Neil Gleason, John E Pachankis, Beáta Bőthe, Shane W Kraus
BACKGROUND AND AIMS: Since the inclusion of Compulsive Sexual Behavior Disorder (CSBD) in the International Classification of Diseases (11th ed.), there has been little effort placed into developing clinical recommendations for lesbian, gay, bisexual, and queer (LGBQ) clients with this condition. Thus, we develop preliminary clinical recommendations for mental health professionals working with LGBQ clients who may be struggling with CSBD. METHODS: The present paper synthesizes the CSBD literature with advances in LGBQ-affirming care to develop assessment and treatment recommendations...
April 9, 2024: Journal of Behavioral Addictions
https://read.qxmd.com/read/38590967/real-world-retrospective-study-of-prostate-specific-antigen-and-safety-assessment-with-darolutamide-plus-androgen-deprivation-therapy-for-metastasis-hormone-sensitive-prostate-cancer
#36
JOURNAL ARTICLE
Jia Liu, Shenghan Wang, Yong Yang, Shuo Wang, Davide Campobasso, Yu Guang Tan, Qiang Gao, Lin Yang, Yudong Cao, Yongpeng Ji, Peng Du, Bao Zhang
BACKGROUND: ARASENS has demonstrated the efficacy and safety for darolutamide (DARO) with androgen deprivation therapy (ADT) plus docetaxel in metastasis hormone-sensitive prostate cancer (mHSPC). There is a lack of reports for DARO with ADT in mHSPC though the regimen is used in clinical from time to time. Moreover, recent studies have supported the importance of early and rapid prostate-specific antigen (PSA) reduction, which correlates with reduced disease progression and improved survival in patients with mHSPC...
March 31, 2024: Translational Andrology and Urology
https://read.qxmd.com/read/38587980/micro-ultrasound-for-the-detection-of-clinically-significant-prostate-cancer-in-biopsy-naive-men-with-negative-mri
#37
JOURNAL ARTICLE
Patrick Albers, Jacob Bennett, Moira Evans, Ella St Martin, Betty Wang, Stacey Broomfield, Anaïs Medina Martín, Wendy Tu, Christopher Fung, Adam Kinnaird
INTRODUCTION: Despite a negative magnetic resonance imaging (MRI), some patients may still harbor clinically significant prostate cancer (csPCa, Gleason grade group ≥2). High-resolution micro-ultrasound (microUS) is a novel imaging technology that could visualize csPCa that is missed by MRI. METHODS: This retrospective review included 1011 consecutive patients biopsied between September 2021 and July 2023 in Alberta, Canada. Among them were 103 biopsy-naive patients with negative MRI (Prostate Imaging Reporting & Data System [PI-RADS] ≤2) undergoing microUS-informed prostate biopsy (n=56) scored using Prostate Risk Identification Using Micro-ultrasound (PRI-MUS) or standard transrectal ultrasound prostate biopsy (n=47)...
April 2, 2024: Canadian Urological Association Journal
https://read.qxmd.com/read/38587577/psoas-mass-index-at-the-level-of-the-third-lumbar-vertebra-on-computed-tomography-is-a-prognostic-predictor-for-metastatic-castration-sensitive-prostate-cancer
#38
JOURNAL ARTICLE
Shunsuke Owa, Takeshi Sasaki, Ryota Ikadai, Yusaku Tabata, Yushiro Takeuchi, Taketomo Nishikawa, Momoko Kato, Shinichiro Higashi, Yusuke Sugino, Satoru Masui, Kouhei Nishikawa, Takahiro Inoue
BACKGROUND: Computed tomography-defined low skeletal muscle mass is associated with oncological outcomes in patients with prostate cancer. However, its association with the outcomes of hormone-treated metastatic castration-sensitive prostate cancer remains unclear. We aimed to determine the association between metastatic castration-sensitive prostate cancer and psoas muscle parameters. METHODS: We retrospectively reviewed 121 patients with N1 and/or M1 metastatic castration-sensitive prostate cancer who underwent primary androgen deprivation therapy between 2005 and 2021, either by administration of luteinizing hormone-releasing hormone agonist/antagonist or by surgical castration accompanied by bicalutamide, a first-generation antiandrogen...
April 8, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38583574/timing-of-radiotherapy-rt-after-radical-prostatectomy-rp-long-term-outcomes-in-the-radicals-rt-trial-nct00541047
#39
JOURNAL ARTICLE
C C Parker, P M Petersen, A D Cook, N W Clarke, C Catton, W R Cross, H Kynaston, W R Parulekar, R A Persad, F Saad, L Bower, G C Durkan, J Logue, C Maniatis, D Noor, H Payne, J Anderson, A K Bahl, F Bashir, D M Bottomley, K Brasso, L Capaldi, P W Cooke, C Chung, J Donohue, B Eddy, C M Heath, A Henderson, A Henry, R Jaganathan, H Jakobsen, N D James, J Joseph, K Lees, J Lester, H Lindberg, A Makar, S L Morris, N Oommen, P Ostler, L Owen, P Patel, A Pope, R Popert, R Raman, V Ramani, A Røder, I Sayers, M Simms, V Srinivasan, S Sundaram, K L Tarver, A Tran, P Wells, J Wilson, A M Zarkar, M K M Parmar, M R Sydes
BACKGROUND: The optimal timing of radiotherapy (RT) after radical prostatectomy for prostate cancer has been uncertain. RADICALS-RT compared efficacy and safety of adjuvant RT versus an observation policy with salvage RT for PSA failure. METHODS: RADICALS-RT was a randomised controlled trial enrolling patients with ≥1 risk factor (pT3/4, Gleason 7-10, positive margins, pre-op PSA≥10ng/ml) for recurrence after radical prostatectomy. Patients were randomised 1:1 to adjuvant RT ("Adjuvant-RT") or an observation policy with salvage RT for PSA failure ("Salvage-RT") defined as PSA≥0...
April 5, 2024: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://read.qxmd.com/read/38583004/is-unilateral-lymphadenectomy-an-option-in-selected-patients-with-prostate-cancer
#40
JOURNAL ARTICLE
Baraa Nakdali Kassab, Pedro De Pablos-Rodríguez, Álvaro Gómez Ferrer, Antonio Coy García, Ana Calatrava Fons, Fuensanta Aragón, Juan Casanova Ramón-Borja, Miguel Ramírez-Backhaus
BACKGROUND: Evidence regarding the relationship between the laterality of lymph node invasion (LNI) and the prostatic lobe affected is limited. Our aim was to review our records of patients with exclusively unilateral localised prostate cancer (PCa) with metastatic LN involvement. METHODS: Between 2006 and 2023, after radical prostatectomy and extended pelvic lymphadenectomy at our centre, thirty patients with intermediate-high risk unilateral PCa and pN1 disease were identified...
March 2024: Archivos Españoles de Urología
keyword
keyword
106912
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.